Pipes argues that many weight loss and muscle peptides sold online have never had rigorous testing. In her view, that leaves their benefits and risks unknown.
Recap by typeshit. Post by Sally Pipes on X.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Researchers identified the patient groups most likely to benefit before starting treatment, giving employers a clinical basis for coverage as costs climb.
She describes her routine as lots of little decisions, like checking yogurt labels for protein, rather than one big change.
Loading…